GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | 8/7/2026 5:15:40 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $29,105,000 | Assets $199,255,000 | EPS -$0.12 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 8/7/2026 8:01:26 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $29,105,000 | Assets $199,255,000 | EPS -$0.12 | Export Earnings Model | |
| GYRE THERAPEUTICS, INC. (GYRE) | 7/15/2026 5:09:46 PM | View | Correction | SEC | 2Q 2026 | ||||||
| GYRE THERAPEUTICS, INC. (GYRE) | 5/8/2026 4:25:06 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $22,519,000 | Assets $162,015,000 | EPS -$0.10 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 5/7/2026 6:06:00 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $22,519,000 | Assets $162,015,000 | EPS -$0.10 | Export Earnings Model | |
| GYRE THERAPEUTICS, INC. (GYRE) | 4/27/2026 4:48:05 PM | View | Proxy | SEC | Y 2025 | ||||||
| GYRE THERAPEUTICS, INC. (GYRE) | 3/13/2026 4:44:42 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $116,588,000 +10.2% | Assets $166,132,000 | EPS $0.02 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 3/12/2026 6:04:36 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $37,195,000 +33.4% | Assets $166,132,000 | EPS -$0.02 | Export Earnings Model | |
| GYRE THERAPEUTICS, INC. (GYRE) | 11/7/2025 4:26:07 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $30,564,000 +19.9% | Assets $159,384,000 | EPS $0.03 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 11/7/2025 6:06:18 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $30,564,000 +19.9% | Assets $159,384,000 | EPS $0.03 | Export Earnings Model | |
| GYRE THERAPEUTICS, INC. (GYRE) | 8/11/2025 5:15:46 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $152,646,000 | |||
| GYRE THERAPEUTICS, INC. (GYRE) | 8/11/2025 4:02:14 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $152,646,000 | Export Earnings Model | |||
| GYRE THERAPEUTICS, INC. (GYRE) | 5/9/2025 4:46:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $129,790,000 | |||
| GYRE THERAPEUTICS, INC. (GYRE) | 5/9/2025 6:02:38 AM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $129,790,000 | Export Earnings Model | |||
| GYRE THERAPEUTICS, INC. (GYRE) | 4/21/2025 5:23:53 PM | View | Proxy | SEC | Y 2024 | ||||||
| GYRE THERAPEUTICS, INC. (GYRE) | 3/17/2025 4:23:16 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $105,757,000 -6.8% | Assets $125,406,000 | EPS $0.05 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 3/17/2025 4:07:24 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $27,872,000 +2.7% | Assets $125,406,000 | Export Earnings Model | ||
| GYRE THERAPEUTICS, INC. (GYRE) | 11/13/2024 4:21:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $25,488,000 -20.5% | Assets $125,240,000 | EPS $0.01 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 11/13/2024 6:05:53 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $25,488,000 -20.5% | Assets $125,240,000 | EPS $0.01 | Export Earnings Model | |
| GYRE THERAPEUTICS, INC. (GYRE) | 8/13/2024 4:19:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $25,225,000 -14.0% | Assets $120,929,000 | EPS $0.01 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 8/13/2024 6:04:27 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $25,225,000 -14.0% | Assets $120,929,000 | EPS $0.01 | Export Earnings Model | |
| GYRE THERAPEUTICS, INC. (GYRE) | 5/13/2024 4:18:48 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $27,172,000 +9.0% | Assets $122,010,000 | EPS $0.03 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 5/9/2024 4:08:52 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $27,172,000 +9.0% | Assets $122,010,000 | EPS $0.03 | Export Earnings Model | |
| GYRE THERAPEUTICS, INC. (GYRE) | 4/29/2024 8:47:52 AM | View | Proxy | SEC | Y 2023 | ||||||
| GYRE THERAPEUTICS, INC. (GYRE) | 3/27/2024 4:49:44 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $113,450,000 +10.9% | Assets $116,539,000 | EPS -$1.41 | |
| GYRE THERAPEUTICS, INC. (GYRE) | 3/26/2024 6:05:00 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $27,148,000 -73.3% | Assets $116,539,000 | EPS -$1.51 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 10/26/2023 5:34:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $32,042,000 | Assets $9,964,000 | EPS $0.05 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/14/2023 1:17:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $29,329,000 | Assets $12,394,000 | EPS $0.02 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/14/2023 6:05:20 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $29,329,000 | Assets $12,394,000 | EPS $0.02 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 7/20/2023 8:58:03 AM | View | Proxy | SEC | Y 2022 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/15/2023 4:45:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $24,931,000 +3,039.9% | Assets $18,750,000 | EPS $0.03 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/30/2023 4:21:12 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $102,290,000 +1,294.0% | Assets $84,753,000 | EPS $0.03 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/14/2022 1:19:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $31,019,000 | EPS -$0.16 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/15/2022 4:50:05 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $83,373,000 | EPS $1.64 | Export Earnings Model | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/15/2022 4:20:42 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $83,373,000 | EPS $1.64 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 7/20/2022 9:17:24 AM | View | Proxy | SEC | Y 2021 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 7/19/2022 8:03:27 AM | View | Proxy | SEC | Y 2021 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/9/2022 4:16:39 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $794,000 -45.9% | Assets $40,274,000 | EPS -$0.46 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/9/2022 1:07:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $794,000 -45.9% | Assets $40,274,000 | EPS -$0.46 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/2/2022 2:39:16 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Rev: $7,338,000 -65.0% | Assets $55,662,000 | EPS -$2.87 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 4/5/2022 6:04:01 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $2,440,000 +20.1% | Assets $55,662,000 | EPS -$0.64 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/31/2022 1:17:42 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $7,338,000 -65.0% | Assets $55,662,000 | EPS -$2.87 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/12/2021 7:25:17 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $2,299,000 +157.4% | Assets $78,537,000 | EPS -$0.80 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/12/2021 7:24:37 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $2,299,000 +157.4% | Assets $78,537,000 | EPS -$0.80 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/5/2021 1:13:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $1,132,000 -31.7% | Assets $101,786,000 | EPS -$0.64 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/5/2021 8:09:21 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $1,132,000 -31.7% | Assets $101,786,000 | EPS -$0.64 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/6/2021 1:13:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $1,467,000 -91.0% | Assets $119,076,000 | EPS -$0.79 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/6/2021 8:08:37 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $1,467,000 -91.0% | Assets $119,076,000 | EPS -$0.79 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 4/27/2021 4:26:23 PM | View | Proxy | SEC | Y 2020 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/4/2021 5:28:23 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $2,031,000 | Assets $94,846,000 | EPS -$0.88 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/4/2021 1:11:35 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $20,948,000 | Assets $94,846,000 | EPS -$2.93 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/5/2020 1:21:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $893,000 | Assets $111,804,000 | EPS -$0.73 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/5/2020 8:13:11 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $893,000 | Assets $111,804,000 | EPS -$0.73 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/6/2020 4:47:37 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $1,658,000 | Assets $123,684,000 | EPS -$0.96 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/6/2020 1:17:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $1,658,000 | Assets $123,684,000 | EPS -$0.96 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/11/2020 4:22:47 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $16,366,000 | Assets $110,563,000 | EPS -$0.28 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/11/2020 1:13:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $16,366,000 | Assets $110,563,000 | EPS -$0.28 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/1/2020 4:51:38 PM | View | Proxy | SEC | Y 2019 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 2/21/2020 6:06:14 AM | View | Financials | Earnings | SEC | Y 2019 | Assets $98,554,000 | EPS -$1.13 | Export Earnings Model | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 2/20/2020 4:13:58 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $98,554,000 | EPS -$4.60 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/7/2019 4:40:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $91,792,000 | EPS -$1.06 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/7/2019 8:02:23 AM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $91,792,000 | EPS -$1.06 | Export Earnings Model | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/1/2019 5:10:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $100,873,000 | EPS -$1.15 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/1/2019 4:26:40 PM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $100,873,000 | EPS -$1.15 | Export Earnings Model | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/2/2019 4:32:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $111,870,000 | EPS -$1.26 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/2/2019 3:02:31 PM | View | Proxy | SEC | Y 2018 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/2/2019 8:03:32 AM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $111,870,000 | EPS -$1.26 | Export Earnings Model | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/8/2019 6:38:46 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $6,000 -99.4% | Assets $124,920,000 | EPS -$2.68 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/7/2019 4:13:45 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $0 | Assets $124,920,000 | EPS -$0.93 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/1/2018 5:17:29 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $133,416,000 | EPS -$0.64 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/1/2018 4:12:14 PM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $133,416,000 | EPS -$0.64 | Export Earnings Model | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/2/2018 5:16:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $139,542,000 | EPS -$0.54 | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/2/2018 4:11:05 PM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $139,542,000 | EPS -$0.54 | Export Earnings Model | ||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/11/2018 4:06:14 PM | View | Proxy | SEC | Y 2017 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/3/2018 5:18:01 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $6,000 -97.8% | Assets $145,886,000 | EPS -$0.56 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/3/2018 5:08:43 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $6,000 -97.8% | Assets $145,886,000 | EPS -$0.56 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/19/2018 5:16:40 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $1,018,000 +155.1% | Assets $39,513,000 | EPS -$7.45 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/2/2018 5:42:19 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $318,000 +347.9% | Assets $39,513,000 | EPS -$0.96 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/2/2017 5:13:06 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $318,000 +191.7% | Assets $34,393,000 | EPS -$1.34 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/2/2017 5:00:12 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $318,000 +191.7% | Assets $34,393,000 | EPS -$1.34 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/3/2017 5:06:42 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $111,000 +1.8% | Assets $39,630,000 | EPS -$2.53 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/3/2017 4:45:27 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $111,000 +1.8% | Assets $39,630,000 | EPS -$2.53 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/18/2017 4:04:57 PM | View | Proxy | SEC | Y 2016 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/11/2017 5:15:32 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $271,000 +148.6% | Assets $29,060,000 | EPS -$4.57 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/11/2017 5:00:20 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $271,000 +148.6% | Assets $29,060,000 | EPS -$4.57 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/8/2017 5:04:12 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $399,000 -77.2% | Assets $38,090,000 | EPS -$21.75 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/8/2017 8:05:26 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $71,000 -34.9% | Assets $38,090,000 | EPS -$4.65 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 1/12/2017 4:02:03 PM | View | Proxy | SEC | Y 2016 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/3/2016 4:32:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $109,000 0.0% | Assets $51,616,000 | EPS -$6.04 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/3/2016 4:30:23 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $109,000 0.0% | Assets $51,616,000 | EPS -$6.04 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/4/2016 8:51:44 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $109,000 -87.3% | Assets $57,219,000 | EPS -$6.33 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 8/4/2016 8:30:32 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $109,000 -87.3% | Assets $57,219,000 | EPS -$6.33 | Export Earnings Model | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 5/5/2016 4:31:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $109,000 -83.8% | Assets $61,543,000 | EPS -$4.71 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 4/25/2016 5:23:39 PM | View | Proxy | SEC | Y 2015 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 3/9/2016 3:36:44 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $1,750,000 -3.5% | Assets $69,521,000 | EPS -$49.99 | |
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/23/2015 4:44:12 PM | View | Proxy | SEC | Y 2014 | ||||||
| CATALYST BIOSCIENCES, INC. (GYRE) | 11/5/2015 5:26:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $109,000 +336.0% | Assets $74,513,000 | EPS -$0.93 | |
| TARGACEPT INC (GYRE) | 7/31/2015 9:55:51 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $859,000 +2,286.1% | Assets $3,331,000 | EPS -$4.60 | |
| TARGACEPT INC (GYRE) | 5/7/2015 2:01:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $672,000 +672.4% | Assets $107,136,000 | EPS -$7.67 | |
| TARGACEPT INC (GYRE) | 3/16/2015 4:43:34 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $1,813,000 +246.7% | Assets $2,981,000 | EPS -$17.99 | |
| TARGACEPT INC (GYRE) | 11/6/2014 12:47:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $25,000 | Assets $116,121,000 | EPS -$4.08 | |
| TARGACEPT INC (GYRE) | 11/5/2014 7:45:59 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $25,000 | Assets $116,121,000 | EPS -$4.08 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 8/7/2014 11:43:52 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $36,000 | Assets $124,515,000 | EPS -$5.68 | |
| TARGACEPT INC (GYRE) | 8/6/2014 7:40:36 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $36,000 | Assets $124,515,000 | EPS -$5.68 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 5/8/2014 3:19:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $87,000 -97.5% | Assets $134,108,000 | EPS -$4.75 | |
| TARGACEPT INC (GYRE) | 5/7/2014 7:45:33 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $87,000 -97.5% | Assets $134,108,000 | EPS -$4.75 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 4/18/2014 8:31:05 AM | View | Proxy | SEC | Y 2013 | ||||||
| TARGACEPT INC (GYRE) | 3/14/2014 3:52:57 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $523,000 -99.1% | Assets $5,274,191 | EPS -$27.29 | |
| TARGACEPT INC (GYRE) | 2/13/2014 7:46:00 AM | View | Financials | Earnings | SEC | Y 2013 | Rev ($3,013,000) | Assets $5,274,191 | EPS -$26.30 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 11/6/2013 12:20:43 PM | Small | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $157,847,000 | EPS -$0.38 | ||
| TARGACEPT INC (GYRE) | 11/5/2013 7:45:52 AM | View | Financials | Earnings | SEC | 3Q 2013 | Assets $157,847,000 | EPS -$0.38 | Export Earnings Model | ||
| TARGACEPT INC (GYRE) | 8/7/2013 4:05:20 PM | Small | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $167,486,000 | EPS -$0.37 | ||
| TARGACEPT INC (GYRE) | 8/6/2013 7:40:33 AM | View | Financials | Earnings | SEC | 2Q 2013 | Assets $167,486,000 | EPS -$0.37 | Export Earnings Model | ||
| TARGACEPT INC (GYRE) | 5/8/2013 3:56:43 PM | Small | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $3,536,000 -84.5% | Assets $178,745,000 | EPS -$0.24 | |
| TARGACEPT INC (GYRE) | 5/7/2013 7:41:09 AM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $3,536,000 -84.5% | Assets $178,745,000 | EPS -$0.24 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 4/17/2013 1:01:34 PM | View | Proxy | SEC | Y 2012 | ||||||
| TARGACEPT INC (GYRE) | 3/15/2013 1:06:25 PM | Small | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $57,860,000 -40.7% | Assets $189,579,000 | EPS -$0.21 | |
| TARGACEPT INC (GYRE) | 2/13/2013 4:10:47 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $590,000 -96.9% | Assets $189,579,000 | EPS -$0.47 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 11/8/2012 3:47:08 PM | Small | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $768,000 -95.9% | Assets $203,499,000 | EPS -$0.24 | |
| TARGACEPT INC (GYRE) | 11/6/2012 4:38:40 PM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $768,000 -95.9% | Assets $203,499,000 | EPS -$0.24 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 8/9/2012 2:36:01 PM | Small | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $33,645,000 +62.2% | Assets $212,622,000 | EPS $0.43 | |
| TARGACEPT INC (GYRE) | 8/7/2012 4:06:35 PM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $33,645,000 +62.2% | Assets $212,622,000 | EPS $0.43 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 5/9/2012 4:50:22 PM | Small | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $22,857,000 -41.4% | Assets $231,104,000 | EPS $0.07 | |
| TARGACEPT INC (GYRE) | 5/3/2012 4:11:24 PM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $22,857,000 -41.4% | Assets $231,104,000 | EPS $0.07 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 4/20/2012 9:54:54 AM | View | Proxy | SEC | Y 2011 | ||||||
| TARGACEPT INC (GYRE) | 3/6/2012 5:05:23 PM | Small | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $97,637,000 +13.9% | Assets $258,126,000 | EPS -$0.27 | |
| TARGACEPT INC (GYRE) | 2/21/2012 12:00:00 AM | View | Financials | Earnings | SEC | Y 2011 | Rev $18,945,000 -19.4% | Assets $258,126,000 | EPS -$0.29 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 11/3/2011 1:15:35 PM | Small | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $18,955,000 -13.0% | Assets $279,739,000 | EPS -$0.27 | |
| TARGACEPT INC (GYRE) | 11/1/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $18,955,000 -13.0% | Assets $279,739,000 | EPS -$0.27 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 8/9/2011 4:53:42 PM | Small | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $20,743,000 -0.8% | Assets $300,018,000 | EPS -$0.07 | |
| TARGACEPT INC (GYRE) | 8/4/2011 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $20,743,000 -0.8% | Assets $300,018,000 | EPS -$0.07 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 5/5/2011 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $38,994,000 | EPS $0.41 | Export Earnings Model | ||
| TARGACEPT INC (GYRE) | 4/21/2011 2:39:21 PM | View | Proxy | SEC | Y 2010 | ||||||
| TARGACEPT INC (GYRE) | 2/10/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Rev $23,495,000 | Assets $262,787,000 | EPS -$0.07 | Export Earnings Model | |
| TARGACEPT INC (GYRE) | 11/4/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $21,798,000 | EPS $0.08 | Export Earnings Model | ||
| TARGACEPT INC (GYRE) | 8/4/2010 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $20,902,000 | EPS $0.13 | Export Earnings Model | ||
| TARGACEPT INC (GYRE) | 5/5/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| TARGACEPT INC (GYRE) | 4/16/2010 1:01:57 PM | View | Proxy | SEC | Y 2009 | ||||||
| TARGACEPT INC (GYRE) | 4/16/2010 1:01:57 PM | View | Proxy | SEC | Y 2009 | ||||||
| TARGACEPT INC (GYRE) | 2/11/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Export Earnings Model | ||||
| TARGACEPT INC (GYRE) | 11/5/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model | ||||
| TARGACEPT INC (GYRE) | 8/5/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| TARGACEPT INC (GYRE) | 5/11/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| TARGACEPT INC (GYRE) | 4/23/2009 2:54:55 PM | View | Proxy | SEC | Y 2008 | ||||||
| TARGACEPT INC (GYRE) | 2/12/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |